Literature DB >> 31420406

Equivalent Doses Matter, Rather Than Types.

Norio Hanafusa1, Ken Tsuchiya2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31420406      PMCID： PMC6727259          DOI： 10.1681/ASN.2019060569

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  4 in total

1.  Dosing darbepoetin alfa.

Authors:  Allen R Nissenson
Journal:  Am J Kidney Dis       Date:  2002-10       Impact factor: 8.860

2.  Epoetin requirements predict mortality in hemodialysis patients.

Authors:  Yi Zhang; Mae Thamer; Kevin Stefanik; James Kaufman; Dennis J Cotter
Journal:  Am J Kidney Dis       Date:  2004-11       Impact factor: 8.860

3.  Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis.

Authors:  Yusuke Sakaguchi; Takayuki Hamano; Atsushi Wada; Ikuto Masakane
Journal:  J Am Soc Nephrol       Date:  2019-04-23       Impact factor: 10.121

4.  Long-term intravenous epoetin-alpha / darbepoetin-alpha ratio in iron-replete hemodialysis patients.

Authors:  Andrea Icardi; Paolo Sacco; Francesca Salvatore; Umberto Romano
Journal:  J Nephrol       Date:  2007 Jan-Feb       Impact factor: 3.902
  4 in total
  3 in total

1.  Authors' Reply.

Authors:  Yusuke Sakaguchi; Takayuki Hamano; Atsushi Wada; Ikuto Masakane
Journal:  J Am Soc Nephrol       Date:  2019-08-16       Impact factor: 10.121

2.  Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure: A randomized, open-label, parallel-group, non-inferiority Phase III trail.

Authors:  Nan Chen; Changying Xing; Jianying Niu; Bicheng Liu; Junzhou Fu; Jiuyang Zhao; Zhaohui Ni; Mei Wang; Wenhu Liu; Jinghong Zhao; Ling Zhong; Xiongfei Wu; Wenge Li; Yuqing Chen; Wei Shi; Jianghua Chen; Aiping Yin; Ping Fu; Rong Wang; Gengru Jiang; Fanfan Hou; Guohua Ding; Jing Chen; Gang Xu; Yuichiro Kondo; Yuliang Su; Changlin Mei
Journal:  Chronic Dis Transl Med       Date:  2022-03-29

3.  Factors affecting pre-end-stage kidney disease haemoglobin control and outcomes following dialysis initiation: a nationwide study.

Authors:  Yang Xu; Marie Evans; Peter Barany; Glen James; Arvid Sjölander; Juan Jesus Carrero
Journal:  Clin Kidney J       Date:  2021-02-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.